Nestlé Health Science and Enterome are to co-develop and commercialise a series of microbiome-based immunotherapies for food allergies and inflammatory bowel disease (IBD).
Angel Yeast has embarked on a human clinical study that looks that the effects of a yeast-based probiotics on adults suffering from inflammatory bowel disease (IBD).
Certain probiotics may have a pathogenesis-specific effect on inflammatory reactions in inflammatory bowel disease (IBD) patients, according to a Chinese study.